ArticleActive
Billing and Coding: MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health)
A57619
Effective: November 25, 2021
Updated: December 31, 2025
Policy Summary
This policy provides billing and coding instructions for reporting the Oncotype DX Breast Cancer for DCIS assay: use PLA code 0045U, report one unit of service, and include the appropriate ICD-10-CM diagnosis. The DEX Z-Code identifier must be entered adjacent to the CPT code in the specified electronic or paper claim fields (Part B: Loop 2400/SV101-7 or Item 19; Part A: SV202-7 or UB04 Block 80).
Coverage Criteria Preview
Key requirements from the full policy
"Claims for the Oncotype DX Breast Cancer for DCIS test (Genomic Health) should be reported using the specified billing/coding instructions in this policy."
Sign up to see full coverage criteria, indications, and limitations.